Related Experiment Video
Updated: Feb 25, 2026

Transplantation Into the Mouse Ovarian Fat Pad
Published on: September 7, 2016
Epigenetics in ovarian cancer
Yanina Natanzon1, Ellen L Goode1, Julie M Cunningham2
1Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA.
Abstract:
Ovarian cancer is a disease with a poor prognosis and little progress has been made to improve treatment. It is now recognized that there are several histotypes of ovarian cancer, each with distinct epidemiologic and genomic characteristics. Cancer therapy is moving beyond classical chemotherapy to include epigenetic approaches. Epigenetics is the dynamic regulation of gene expression by DNA methylation and histone post translational modification in response to environmental cues. Improvement in technology to study DNA methylation has enabled a more agnostic approach and, with larger samples sets, has begun to unravel how epigenetics contributes to the etiology, response to chemotherapy and prognosis in of ovarian cancer. Investigations into histone modifications in ovarian cancer are more nascent. Much more is needed to be done to fully realize the potential that epigenetics holds for ovarian cancer clinical care.
Insights
Epigenetic modifications, including DNA methylation, are crucial in understanding ovarian cancer. Further research into histone modifications is needed to improve patient treatment and prognosis.
Area of Science:
- Oncology
- Molecular Biology
- Epigenetics
Background:
- Ovarian cancer has a poor prognosis with limited treatment advancements.
- Distinct histotypes of ovarian cancer exhibit unique epidemiologic and genomic profiles.
- Cancer therapy is evolving to incorporate epigenetic strategies beyond traditional chemotherapy.
Purpose of the Study:
- To explore the role of epigenetics in ovarian cancer etiology, treatment response, and prognosis.
- To highlight the impact of DNA methylation and histone modifications in ovarian cancer.
- To underscore the need for further investigation into epigenetic mechanisms for clinical application.
Main Methods:
- Utilizing advanced technologies to study DNA methylation patterns.
- Analyzing large sample sets to identify epigenetic contributions.
- Initiating investigations into histone modifications in ovarian cancer.
Main Results:
- Improved DNA methylation analysis has begun to elucidate its role in ovarian cancer.
- Epigenetic factors influence disease etiology, chemotherapy response, and patient outcomes.
- Research into histone modifications in ovarian cancer is in its early stages.
Conclusions:
- Epigenetic approaches, particularly DNA methylation, offer promising avenues for ovarian cancer research.
- Further investigation into histone modifications is essential for unlocking the full potential of epigenetics in ovarian cancer care.
- Realizing the clinical potential of epigenetics requires continued research and technological advancement.
Related Concept Videos
Epigenetic Regulation
X-chromosome...
Epigenetic Regulation
Oogenesis
Genomic Imprinting and Inheritance
The expression of some genes depends on which parent passed the gene to the offspring, through a phenomenon known as...
Nondisjunction
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

